FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3921838 · Received July 9, 2014

Report

Report Number
2124215-2014-10876
Event Type
Malfunction
Date Received
July 9, 2014
Date of Event
December 1, 2012
Report Date
April 29, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT ATRIAL (RA) LEAD EXHIBITED LOW, OUT OF RANGE PACING LEAD IMPEDANCE MEASUREMENTS LESS THAN 200 OHMS. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) REVIEWED THE LATEST SEND FROM THE REMOTE MONITORING SYSTEM AND DISCUSSED THAT SIGNALS ON THE ATRIAL CHANNEL MAY INDICATE POTENTIAL NOISE. FURTHERMORE, THERE APPEARED TO BE ATRIAL UNDERSENSING ON THE PRESENTING ELECTROGRAM (EGM). A REVIEW ON THE ARRHYTHMIA LOGBOOK DETERMINED THAT THERE WAS A HISTORY OF OVERSENSED NOISE ON THE ATRIAL CHANNEL; HENCE, DEVICE PROGRAMMING WAS DONE. SUBSEQUENT INFORMATION WAS RECEIVED INDICATING THAT THE CAUSE OF THE OBSERVATION WAS NOT CONCLUSIVELY DETERMINED AND ADDITIONAL PROGRAMMING WILL BE PERFORMED ON THE PATIENT¿S NEXT CLINIC VISIT. THE SYSTEM REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
399238 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 55 YR E110| 4087| 0158| A135